ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer
Friday, July 10, 2020
Submitted by
Source
Source Name: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2020.01.073
The authors examined The National Cancer Database for patients who refused recommended surgery and elected stereotactic body radiation therapy (SBRT) for stage I/II non-small cell lung cancer.
Printer-friendlyShare
